Startup's Fortunes Depend On Success Of High-Tech Sponge

REDWOOD CITY, CALIF. —Don’t look for high-tech razzle-dazzle at Advanced Polymer Systems Inc. (APS). Unlike most of its entrepreneurial neighbors located in the creative ferment of the San Francisco Bay area, APS is not built upon some headline-grabbing new technology. There are no genetically engineered organisms here, no new drugs poised to save the world, no superconducting substances ready to revolutionize electronics. Founded in 1983, APS is anchored upon a relatively humdru

Written byLiz Marshall
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

REDWOOD CITY, CALIF. —Don’t look for high-tech razzle-dazzle at Advanced Polymer Systems Inc. (APS). Unlike most of its entrepreneurial neighbors located in the creative ferment of the San Francisco Bay area, APS is not built upon some headline-grabbing new technology. There are no genetically engineered organisms here, no new drugs poised to save the world, no superconducting substances ready to revolutionize electronics. Founded in 1983, APS is anchored upon a relatively humdrum piece of work known as the microsponge.

The story of the company emphasizes yet again the importance of having the right combination of imagination and hard-nosed practicality in a startup. On the one hand, the original management team of APS was family grounded in reality. They realized that the entrepreneurial fever they had to offer could take a company only so far; eventually the time would come when they’d be required to bow out alet big-league management complete ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies